Compare ITI Pharma and Healthcare Fund vs SBI Healthcare Opportunities Fund
Risk
Very High
Very High
Rating
1.0
4.0
Min SIP Amount
₹500
₹500
Expense Ratio
2.35
1.93
NAV
₹15.56
₹428.69
Fund Started
18 Oct 2021
04 Jun 1999
Fund Size
₹210.46 Cr
₹3822.73 Cr
Exit Load
Exit load of 0.50%, if redeemed within 3 months.
Exit load of 0.50% if redeemed within 15 days
1 Year
3.52%
7.42%
3 Year
20.71%
25.82%
5 Year
-
17.14%
Equity
98.24%
98.53%
Cash
1.76%
1.39%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 10.76% |
Divi's Laboratories Ltd. | 8.96% |
Apollo Hospitals Enterprise Ltd. | 6.21% |
Max Healthcare Institute Ltd. | 5.49% |
Torrent Pharmaceuticals Ltd. | 4.98% |
Aurobindo Pharma Ltd. | 4.55% |
Lupin Ltd. | 3.69% |
Fortis Healthcare Ltd. | 3.66% |
Alkem Laboratories Ltd. | 3.36% |
Aster DM Healthcare Ltd. | 2.81% |
Sun Pharmaceutical Industries Ltd. | 10.02% |
Divi's Laboratories Ltd. | 6.96% |
Apollo Hospitals Enterprise Ltd. | 5.46% |
Max Healthcare Institute Ltd. | 5.01% |
Lupin Ltd. | 4.73% |
Acutaas Chemicals Ltd. | 4.50% |
Torrent Pharmaceuticals Ltd. | 4.14% |
Aether Industries Ltd. | 3.67% |
Biocon Ltd. | 3.60% |
Aster DM Healthcare Ltd. | 3.47% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
18 Oct 2021
04 Jun 1999
